CEFTRIAXONE PANPHARMA 1 g, powder for solution for injection 25 bottles of 1.193 g
Active ingredients: Ceftriaxone, Ceftriaxone sodium heptahydrate
Commercialized according to BDPMDispensing in France: Prescription only
Powder for solution for injection25 bottles of 1.193 gintramusculaire;intraveineuse
No current ANSM shortage notice is included
Package details
Original BDPM fields are shown in French.
- Official name
- CEFTRIAXONE PANPHARMA 1 g, poudre pour solution injectable
- Pharmaceutical form
- poudre pour solution injectable
- Route of administration
- intramusculaire;intraveineuse
- Presentation description
- 25 flacon(s) en verre de 1,193 g
- Marketing authorisation holder
- PANPHARMA
- Reimbursement according to BDPM
- —
- Approval for use in healthcare institutions
- non
- Commercialization declaration date
- 17 Nov 2022
- Prescription and dispensing conditions
- Prescription only
- List I: prescription-only medicine
- Enhanced ANSM monitoring
- No
BDPM identifiers
CIS
68026724CIP73581836CIP133400935818362Composition in BDPM
| Component | Amount per unit | Source type |
|---|---|---|
| CEFTRIAXONE SODIQUEpoudre | — | SA |
| CEFTRIAXONE BASEpoudre | 1 g · un flacon de poudre | FT |
Information is based on BDPM data and is for reference only. Consult a doctor before use.
Other packages of this medicine
The same medicine in another pack size, according to BDPM.
Similar medicines
Similar medicines are listed using the official BDPM catalog. Availability must be checked separately. Consult a doctor or pharmacist before switching medicines.